REFERENCIAS

1. Harpaz R, Ortega-Sanchez IR, Seward JF, et al. Prevention of Herpes Zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008 Mar 28;57(RR-5):1-30.

2. Mueller NH, Gilden DH, Cohrs RJ, et al. Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis of Disease and Latency. Neurologic Clinics. 2008 Nov;26(4):675-97.

3. Cohen EJ, Jeng BH, Herpes Zoster: A Brief Definitive Review. Cornea. 2021 Aug;40(8):943-949.

4. Koshy E, Mengting L, Kumar H, et al. Epidemiology, treatment and prevention of herpes zoster: A comprehensive review. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):251-262.

5. Schmader K, Oxman M, Keay S, et al. Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med. 2007;23(3):615-632, vii-viii.

6. Kawai K, Gebremeskel BG, Acosta CJ, et al. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014 Jun 10;4(6):e004833.

7. Hadley GR, Gayle JA, Ripoll J, Post-herpetic Neuralgia: a Review. Curr Pain Headache Rep. 2016;20(3):17.

8. Bader MS, Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgrad Med. 2013 Sep;125(5):78-91.